Jan 09 2026 This Week in Cardiology

The limits of knowing coronary artery disease anatomy, fish oil and AF risk, a new drug for PSVT, and maybe I was wrong about a drug for AF conversion (the RAFF4 trial). These are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only . To read a partial transcript or to comment, visit: I Prediction of CAD is hard — even if you have anatomy CCTA in Prediction of First Coronary Events II Fish Oil and AF (and as a bonus we learn again about analytic flexibility) Are Fish Oils on the Hook for AF Risk? Omega-3 and Fish Oil Use With Risk of AF Effect of Long-Term Marine Omega-3 Fatty Acids on the Risk of AF RESPECT-EPA Trial Association Between Omega-3 Fatty Acids and AF: Meta Analysis Fish Oil Supplements and Risk of AF Editorial: Fish Oil Supplements and AF Risk III A New Drug for PSVT FDA Approval RAPID trial IV AF Conversion with Vernakalant RAFF4 Trial Editorial: Rapid Cardioversion for Acute AF VI A Quick Note on HFpEF Med Op-Ed: Avalanche Survival, HFpEF Skepticism, and More You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. Questions or feedback, please contact news@medscape.net

You can listen to Jan 09 2026 This Week in Cardiology online on Radio and Podcast. Open the player on this page to stream the available audio.

Jan 09 2026 This Week in Cardiology is an episode from This Week in Cardiology by Medscape Podcasts.

This episode is 28:28 long.

This episode was published on Jan 9, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from This Week in Cardiology when more episodes are available from the podcast feed.